Patents Assigned to TRIMED BIOTECH GMBH
  • Methods for producing dendritic cells with an siRNA that interferes with MAPKAPK2 expression
    Patent number: 9303246
    Abstract: The present invention relates to a method for producing dendritic cells and their use in medicaments by genetic engineering aimed at functionally improving their therapeutic efficacy in the treatment of cancer, microbial infections, allergies, auto-immune diseases or organ and stem cell transplant rejection.
    Type: Grant
    Filed: December 12, 2008
    Date of Patent: April 5, 2016
    Assignee: TRIMED BIOTECH GMBH
    Inventors: Thomas Felzmann, Alexander Michael Dohnal
  • Method for Producing Dendritic Cells
    Publication number: 20100285072
    Abstract: The present invention relates to a method for producing dendritic cells and their use in medicaments by genetic engineering aimed at functionally improving their therapeutic efficacy in the treatment of cancer, microbial infections, allergies, auto-immune diseases or organ and stem cell transplant rejection.
    Type: Application
    Filed: December 12, 2008
    Publication date: November 11, 2010
    Applicant: TRIMED BIOTECH GMBH
    Inventors: Thomas Felzmann, Alexander Michael Dohnal